An intensive 2-day practical course equipping you with essential skills for licensing, partnerships, and negotiations in the life sciences industry
Are you ready to master the art and science of deal making in the dynamic world of pharma and biotech? Join our intensive, practical 2-day course designed to equip you with the essential skills and knowledge needed to navigate the complex landscape of licensing, partnerships, and negotiations.
Learn from industry experts who have deep understanding of valuation approaches, risk assessment methodologies, and deal structuring techniques that are currently shaping the pharma-biotech world. Our carefully designed agenda covers all crucial topics, ensuring you leave with a comprehensive understanding of the deal-making process.
Our course offers a hands-on approach, providing you with practical tools, templates, and Excel-based valuation models that you can immediately apply in your professional endeavors. Whether you're involved in investment rounds, M&A, licensing deals, or strategic development decisions, this course will equip you with the skills to produce accurate valuations and make informed business decisions.
Our course leader, Dimitri F Dimitriou, FRSM, is a renowned authority in dealmaking in the pharma/biotech sector, with 35 years' experience in both big pharma companies and biotechs. Dimitri has been involved in over 200 deals. With vast sector-specific knowledge and experience, he will guide you through the intricacies of deal making, sharing valuable insights and case studies.
Our course attracts a diverse audience of executives from pharma, biotech, and related industries. This provides a unique opportunity to network, share experiences, and learn from the successes and challenges faced by your peers. Engage in stimulating discussions, forge new connections, and expand your professional network.
Dimitri has over 35 years' experience in the pharmaceutical and biotech industry. Over the last 20 years, he is the founder and Managing Director of DyoDelta Biosciences, an advisory company specializing in providing support in putting together corporate collaborations in the Life Sciences.
He has been involved in over 200 pharma/biotech agreements, mostly cross-border transactions and has been a speaker or chairman in 40 conferences. He is a co-founder and former CEO of ImmuPharma plc, a drug development biotech company listed on AIM of the London Stock Exchange.
His past roles include Senior Director, Worldwide Business Development at GlaxoSmithKline, where he was responsible for worldwide transactions with a focus on licensing novel products for development and commercialization. He was also the head for transactions in Europe at Bristol-Myers Squibb.
This condensed 2-day course provides a comprehensive overview of the key aspects of deal making in the pharma and biotech industry, as well as MedTech and Digital Health. Participants gain valuable insights into the deal-making process, including preparation, due diligence, licensing, IP protection, valuation, negotiation, and relationship management.
Join industry leaders and peers for an immersive learning experience that will accelerate your career and drive business success in the life sciences sector.
Register NowOur team is ready to help. Contact us for further information, or group booking enquiry.
Contact Us Connect on LinkedIn